Healthcare & Life Sciences
NovaGo Therapeutics
Switzerlandwww.novagotherapeutics.com/company-news/
aliveseries-a
series-a
Stage
1
Investors
About
NovaGo Therapeutics is a clinical stage biotech company developing human antibody therapeutics that promote nerve regeneration and repair, focusing on treatments for acute spinal cord injury and diabetic retinopathy.
Explore NovaGo Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.